Amgen, Allergan apply for European nod for Avastin biosimilar

(Reuters) - Amgen Inc and Allergan Plc said they have submitted an application to the European health regulator seeking approval of their biosimilar version of Roche Holding AG's blockbuster cancer treatment, Avastin.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news